SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (19889)10/18/2004 7:15:32 PM
From: Madharry   of 78670
 
I own a little frx. i like amgn but there's stuff i like more.
I couldnt resist repurchasing CEGE at these levels which i believe is a multi year low. It fits my concept of a value biotech. The stock is selling for a small premium to book . It was spanked down strongly because of convertible debt offering. Now I believe the price is right and I have dipped my toe into the water. This is the company that spun off Abgenix and it has a minority owned(25%) sub-ceragene i think that is working on treatments for alzheimers and parkinsons. Based on the info available i believe its a bargain at these levels. Do any of you have any thoughts about ACE you would care to share. I looked at it when it was in the high 30s and it looked pretty good to me. From what I read it almost looks as though this rigging of bids was mostly arranged by MMC. and the reinsurers just fell into line. Of course i dont work in the business and the reality could be different from my speculation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext